Title |
Utility of serum procalcitonin values in patients with acute exacerbations of chronic obstructive pulmonary disease: a cautionary note
|
---|---|
Published in |
International Journal of Chronic Obstructive Pulmonary Disease, February 2012
|
DOI | 10.2147/copd.s29149 |
Pubmed ID | |
Authors |
Ann R Falsey, Kenneth L Becker, Andrew J Swinburne, Eric S Nylen, Richard H Snider, Maria A Formica, Patricia A Hennessey, Mary M Criddle, Derick R Peterson, Edward E Walsh |
Abstract |
Serum procalcitonin levels have been used as a biomarker of invasive bacterial infection and recently have been advocated to guide antibiotic therapy in patients with chronic obstructive pulmonary disease (COPD). However, rigorous studies correlating procalcitonin levels with microbiologic data are lacking. Acute exacerbations of COPD (AECOPD) have been linked to viral and bacterial infection as well as noninfectious causes. Therefore, we evaluated procalcitonin as a predictor of viral versus bacterial infection in patients hospitalized with AECOPD with and without evidence of pneumonia. |
X Demographics
Geographical breakdown
Country | Count | As % |
---|---|---|
Unknown | 1 | 100% |
Demographic breakdown
Type | Count | As % |
---|---|---|
Practitioners (doctors, other healthcare professionals) | 1 | 100% |
Mendeley readers
Geographical breakdown
Country | Count | As % |
---|---|---|
United Kingdom | 1 | 2% |
Greece | 1 | 2% |
Unknown | 40 | 95% |
Demographic breakdown
Readers by professional status | Count | As % |
---|---|---|
Researcher | 8 | 19% |
Other | 7 | 17% |
Student > Bachelor | 6 | 14% |
Student > Ph. D. Student | 4 | 10% |
Student > Master | 3 | 7% |
Other | 6 | 14% |
Unknown | 8 | 19% |
Readers by discipline | Count | As % |
---|---|---|
Medicine and Dentistry | 26 | 62% |
Economics, Econometrics and Finance | 2 | 5% |
Agricultural and Biological Sciences | 2 | 5% |
Pharmacology, Toxicology and Pharmaceutical Science | 1 | 2% |
Biochemistry, Genetics and Molecular Biology | 1 | 2% |
Other | 2 | 5% |
Unknown | 8 | 19% |